ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Mar 03, 2023 10:18 JST
H World Group sells its shares in Accor, both companies to continue partnership in developing their hotel operations in China
HONG KONG, Mar 03, 2023 - (ACN Newswire) - H World Group recently announced that it completed the disposal of its 3.7% stake in Accor. The proceeds of this transaction will be redeployed for the development of the Group's core business. After this transaction, H World Group no longer owns any stake in Accor, but both sides will continue to develop their successful partnership.
As world-renowned hotel groups, H World Group and Accor established strategic partnership with cross shareholding in 2016. Under the agreement, H World Group has the master franchisee rights for Mercure, Ibis and Ibis Styles, as well as co-development rights for Grand Mercure and Novotel in the Greater China Region. By the end of 2022, H World Group operates 468 hotels in China under this agreement, with 143 properties in the pipeline scheduled to open over the next few years. Accor remains a key partner of H World Group in China as both sides push forth their efforts to expand and innovate in the hospitality industry.
H World Group is a key player in the global hotel industry, operating multiple hotel and apartment brands with coverage from luxury to economy markets. H World's brands include Hi Inn, HanTing Hotel, JI Hotel, Starway Hotel, Orange Hotel, Crystal Orange Hotel, Manxin Hotel, Madison Hotel, Joya Hotel, Blossom House, Ni Hao Hotel, CitiGO Hotel, Steigenberger Hotels & Resorts, MAXX, Jaz in the City, IntercityHotel, Zleep Hotels, Steigenberger Icon and Song Hotels.
Sectors: Hospitality
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time
Mar 10, 2025 20:24 JST
CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI
Mar 10, 2025 12:10 JST
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 07, 2025 16:24 JST
NEC improves the energy efficiency and floor space density of 5G Mobile Core systems
Mar 06, 2025 13:20 JST
Unmanned Aerial Vehicles Being Developed by MHI Used in Demonstration of Automated Transport and Unloading of Heavy Cargo in Disaster Areas
Mar 05, 2025 16:11 JST
Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan
Mar 05, 2025 09:09 JST
MHI-MS Completes Domestic Development of Vehicle Transport Robot
Mar 04, 2025 19:39 JST
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia
Mar 04, 2025 17:22 JST
Prideone Entertainment announces concept for post-war film to mark 80th anniversary of the end of World War II
Mar 04, 2025 16:00 JST
NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration
Mar 03, 2025 20:25 JST
Space Compass and NTT DOCOMO Successfully Demonstrate Data Connectivity to 4G Devices via HAPS at 20 km Above Kenya
Mar 03, 2025 20:14 JST
TOPPAN and DOCOMO Agree to Innovate Next-Generation 6G Services Using FEEL TECH Communication Technology
Mar 03, 2025 18:32 JST
Rakuten Mobile Partners with Fujitsu to Accelerate 5G Network Expansion
Mar 03, 2025 18:23 JST
Fujitsu unveils 1FINITY 800G ZR/ZR+ coherent pluggable transceivers
Mar 03, 2025 17:58 JST
NEC develops and commercializes 5G-compatible virtualized base stations (vRAN)
Mar 03, 2025 17:42 JST
MHI-MS Delivers Merging Support Information System for Autonomous Truck Trial Project by MLIT
Mar 03, 2025 16:09 JST
"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell"
Mar 03, 2025 15:41 JST
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Mar 03, 2025 13:53 JST
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
Feb 28, 2025 16:57 JST
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Feb 28, 2025 12:31 JST
More Latest Release >>